Ghent University Academic Bibliography

Advanced

Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus.

Niek Sanders UGent, Stefaan De Smedt UGent, SH CHENG and Jo Demeester UGent (2002) GENE THERAPY. 9(6). p.363-371
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
GENE THERAPY
volume
9
issue
6
pages
363-371 pages
Web of Science type
Article
Web of Science id
000174694000001
JCR category
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
JCR impact factor
5.616 (2002)
JCR rank
7/130 (2002)
JCR quartile
1 (2002)
ISSN
0969-7128
language
English
UGent publication?
yes
classification
A1
id
149607
handle
http://hdl.handle.net/1854/LU-149607
date created
2004-01-14 13:38:00
date last changed
2016-12-19 15:38:18
@article{149607,
  author       = {Sanders, Niek and De Smedt, Stefaan and CHENG, SH and Demeester, Jo},
  issn         = {0969-7128},
  journal      = {GENE THERAPY},
  language     = {eng},
  number       = {6},
  pages        = {363--371},
  title        = {Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus.},
  volume       = {9},
  year         = {2002},
}

Chicago
Sanders, Niek, Stefaan De Smedt, SH CHENG, and Jo Demeester. 2002. “Pegylated GL67 Lipoplexes Retain Their Gene Transfection Activity After Exposure to Components of CF Mucus.” Gene Therapy 9 (6): 363–371.
APA
Sanders, N., De Smedt, S., CHENG, S., & Demeester, J. (2002). Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. GENE THERAPY, 9(6), 363–371.
Vancouver
1.
Sanders N, De Smedt S, CHENG S, Demeester J. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. GENE THERAPY. 2002;9(6):363–71.
MLA
Sanders, Niek, Stefaan De Smedt, SH CHENG, et al. “Pegylated GL67 Lipoplexes Retain Their Gene Transfection Activity After Exposure to Components of CF Mucus.” GENE THERAPY 9.6 (2002): 363–371. Print.